
Caregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.
You meet your patient late one evening in the emergency department: a 6-year-old boy comfortably asleep as his mother relates their day's events to you.






